Previous close | 9.28 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | 2.191M |
Beta (5Y monthly) | 1.91 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.30 |
Earnings date | 08 May 2023 - 12 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -14.29% and 0.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NEWPORT BEACH, Calif., March 08, 2023--Evolus reports financial results for the fourth quarter and full year ended December 31, 2022 and provides a business update
NEWPORT BEACH, Calif., February 28, 2023--Evolus announces that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida.